Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Journal of Inborn Errors of Metabolism and Screening |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942021000100401 |
Resumo: | Abstract Inborn errors of metabolism are predominantly autosomal-recessive disorders, but several follow an X-linked pattern of inheritance. They are called X-linked recessive, if the female carriers are asymptomatic, and are called X-linked dominant disorders, if almost all females are affected. Conditions, in which some females have symptoms while others are asymptomatic lifelong are simply referred to as X-linked. The aim of this review is to point out the variability in clinical manifestation of affected females in some X-linked metabolic disorders and to discuss on the basis of these examples possible mechanisms that may explain the broad phenotypic spectrum, such as the type of the underlying mutation, the issue of autonomous versus non-autonomous gene expression and the degree of skewing of X-inactivation. The use of the terms “X-linked dominant” and “X-linked recessive” will be discussed. |
id |
IGPT-1_ee48450551e6027031d67db4fca57d48 |
---|---|
oai_identifier_str |
oai:scielo:S2326-45942021000100401 |
network_acronym_str |
IGPT-1 |
network_name_str |
Journal of Inborn Errors of Metabolism and Screening |
repository_id_str |
|
spelling |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological ConsiderationsX-linked disordersmetabolic disordersX-inactivationpyruvate dehydrogenasecreatine transportercholesterol biosynthesishypophosphatemic ricketslysosomal storage disorderAbstract Inborn errors of metabolism are predominantly autosomal-recessive disorders, but several follow an X-linked pattern of inheritance. They are called X-linked recessive, if the female carriers are asymptomatic, and are called X-linked dominant disorders, if almost all females are affected. Conditions, in which some females have symptoms while others are asymptomatic lifelong are simply referred to as X-linked. The aim of this review is to point out the variability in clinical manifestation of affected females in some X-linked metabolic disorders and to discuss on the basis of these examples possible mechanisms that may explain the broad phenotypic spectrum, such as the type of the underlying mutation, the issue of autonomous versus non-autonomous gene expression and the degree of skewing of X-inactivation. The use of the terms “X-linked dominant” and “X-linked recessive” will be discussed.Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942021000100401Journal of Inborn Errors of Metabolism and Screening v.9 2021reponame:Journal of Inborn Errors of Metabolism and Screeninginstname:Instituto Genética para Todos (IGPT)instacron:IGPT10.1590/2326-4594-jiems-2020-0024info:eu-repo/semantics/openAccessBeck,Michaeleng2021-03-30T00:00:00Zoai:scielo:S2326-45942021000100401Revistahttp://jiems-journal.org/ONGhttps://old.scielo.br/oai/scielo-oai.phpjiems@jiems-journal.org||rgiugliani@hcpa.edu.br2326-45942326-4594opendoar:2021-03-30T00:00Journal of Inborn Errors of Metabolism and Screening - Instituto Genética para Todos (IGPT)false |
dc.title.none.fl_str_mv |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations |
title |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations |
spellingShingle |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations Beck,Michael X-linked disorders metabolic disorders X-inactivation pyruvate dehydrogenase creatine transporter cholesterol biosynthesis hypophosphatemic rickets lysosomal storage disorder |
title_short |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations |
title_full |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations |
title_fullStr |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations |
title_full_unstemmed |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations |
title_sort |
Clinical Manifestation in Females with X-linked Metabolic Disorders: Genetic and Pathophysiological Considerations |
author |
Beck,Michael |
author_facet |
Beck,Michael |
author_role |
author |
dc.contributor.author.fl_str_mv |
Beck,Michael |
dc.subject.por.fl_str_mv |
X-linked disorders metabolic disorders X-inactivation pyruvate dehydrogenase creatine transporter cholesterol biosynthesis hypophosphatemic rickets lysosomal storage disorder |
topic |
X-linked disorders metabolic disorders X-inactivation pyruvate dehydrogenase creatine transporter cholesterol biosynthesis hypophosphatemic rickets lysosomal storage disorder |
description |
Abstract Inborn errors of metabolism are predominantly autosomal-recessive disorders, but several follow an X-linked pattern of inheritance. They are called X-linked recessive, if the female carriers are asymptomatic, and are called X-linked dominant disorders, if almost all females are affected. Conditions, in which some females have symptoms while others are asymptomatic lifelong are simply referred to as X-linked. The aim of this review is to point out the variability in clinical manifestation of affected females in some X-linked metabolic disorders and to discuss on the basis of these examples possible mechanisms that may explain the broad phenotypic spectrum, such as the type of the underlying mutation, the issue of autonomous versus non-autonomous gene expression and the degree of skewing of X-inactivation. The use of the terms “X-linked dominant” and “X-linked recessive” will be discussed. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942021000100401 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942021000100401 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/2326-4594-jiems-2020-0024 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT) |
publisher.none.fl_str_mv |
Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT) |
dc.source.none.fl_str_mv |
Journal of Inborn Errors of Metabolism and Screening v.9 2021 reponame:Journal of Inborn Errors of Metabolism and Screening instname:Instituto Genética para Todos (IGPT) instacron:IGPT |
instname_str |
Instituto Genética para Todos (IGPT) |
instacron_str |
IGPT |
institution |
IGPT |
reponame_str |
Journal of Inborn Errors of Metabolism and Screening |
collection |
Journal of Inborn Errors of Metabolism and Screening |
repository.name.fl_str_mv |
Journal of Inborn Errors of Metabolism and Screening - Instituto Genética para Todos (IGPT) |
repository.mail.fl_str_mv |
jiems@jiems-journal.org||rgiugliani@hcpa.edu.br |
_version_ |
1754732520279113728 |